You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 14, Issue 4

February-2 2022 - 245 articles

Cover Story: Cancer is a disease with one of the highest mortality rates worldwide. Of the current strategies to study new diagnostic and treating tools, organs-on-a-chip are quite promising regarding the achievement of more personalized medicine. In this review, 75 out of 820 of the most recent published scientific articles were selected and analyzed through a systematic process, following the research guidelines for systematic reviews proposed by PRISMA. The selected articles present different advanced microfluidic platforms where cell culture models were used for the evaluation of cancer treatments’ efficacy and/or toxicity. Overall, the use of organs-on-a-chip presents several advantages when compared to 2D cultures. The combination of different organ models on a chip also contributes to a more accurate evaluation of drug effects. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (245)

  • Review
  • Open Access
13 Citations
3,573 Views
14 Pages

State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent

  • Kangwook Lee,
  • Bo-Young Youn,
  • Yu-Jeong Choi,
  • Seunghwan Moon,
  • Jungkwun Im,
  • Kyongha Cho,
  • Seong-Gyu Ko and
  • Chunhoo Cheon

21 February 2022

Cancer ranks as the first leading cause of death globally. Despite the various types of cancer treatments, negative aspects of the treatments, such as side effects and drug resistance, have been a continuous dilemma for patients. Thus, natural compou...

  • Review
  • Open Access
3 Citations
2,319 Views
9 Pages

21 February 2022

Adenocarcinoma of the esophagus and gastroesophageal junction is a common disease. This disease is significantly more prevalent in men, although the main underlying risk factor has an equal sex distribution. In locally advanced disease, multimodal th...

  • Article
  • Open Access
6 Citations
5,124 Views
13 Pages

Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma

  • Björn-Ole Stüben,
  • Jakob Stuhlfelder,
  • Marius Kemper,
  • Michael Tachezy,
  • Tarik Ghadban,
  • Jakob Robert Izbicki,
  • Carsten Bokemeyer,
  • Marianne Sinn,
  • Karl-Frederick Karstens and
  • Matthias Reeh

21 February 2022

Esophageal cancer is the eighth most common cancer worldwide, with poor prognosis and high mortality. The combination of surgery and systemic therapy provide the best chances for long-term survival. The purpose of this study was to analyze the impact...

  • Systematic Review
  • Open Access
5 Citations
2,807 Views
12 Pages

21 February 2022

Background: CyberKnife-based robotic radiosurgery (RRS) is a widely used treatment modality for various benign and malignant tumors of the central nervous system (CNS) in adults due to its high precision, favorable safety profile, and efficacy. Altho...

  • Article
  • Open Access
2 Citations
2,822 Views
12 Pages

21 February 2022

(1) Background: Facial nerve resection with reconstruction helps achieve optimal outcomes in the treatment of facial nerve invasion (FNI) of parotid cancer. Preoperative imaging is crucial to predict facial nerve reconstruction. The radiological find...

  • Article
  • Open Access
6 Citations
3,320 Views
18 Pages

Effective Penetration of a Liposomal Formulation of Bleomycin through Ex-Vivo Skin Explants from Two Different Species

  • Giulia Ferrari,
  • Lisa Y. Pang,
  • Fabio De Moliner,
  • Marc Vendrell,
  • Richard J. M. Reardon,
  • Andrew J. Higgins,
  • Sunil Chopra and
  • David J. Argyle

21 February 2022

Bleomycin is a chemotherapy agent that, when administered systemically, can cause severe pulmonary toxicity. Bleosome is a novel formulation of bleomycin encapsulated in ultra-deformable (UD) liposomes that may be applicable as a topical chemotherapy...

  • Article
  • Open Access
48 Citations
3,940 Views
17 Pages

Line-Field Confocal Optical Coherence Tomography Increases the Diagnostic Accuracy and Confidence for Basal Cell Carcinoma in Equivocal Lesions: A Prospective Study

  • Charlotte Gust,
  • Sandra Schuh,
  • Julia Welzel,
  • Fabia Daxenberger,
  • Daniela Hartmann,
  • Lars E. French,
  • Cristel Ruini and
  • Elke C. Sattler

21 February 2022

Diagnosing clinically unclear basal cell carcinomas (BCCs) can be challenging. Line-field confocal optical coherence tomography (LC-OCT) is able to display morphological features of BCC subtypes with good histological correlation. The aim of this stu...

  • Article
  • Open Access
9 Citations
2,944 Views
15 Pages

Survival Analysis in Endometrial Carcinomas by Type of Surgical Approach: A Matched-Pair Study

  • Pluvio J. Coronado,
  • Agnieszka Rychlik,
  • Laura Baquedano,
  • Virginia García-Pineda,
  • Maria A. Martínez-Maestre,
  • Denis Querleu and
  • Ignacio Zapardiel

21 February 2022

(1) Background: This study aimed to analyze the impact of surgical approach on survival rates in women diagnosed with endometrial cancer. (2) Methods: A retrospective multicenter cohort of 1382 women diagnosed with EC was performed. A total of 684 (4...

  • Article
  • Open Access
10 Citations
3,448 Views
12 Pages

NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCC

  • Benedikt Schmidl,
  • Michael Siegl,
  • Melanie Boxberg,
  • Fabian Stögbauer,
  • Daniel Jira,
  • Christof Winter,
  • Leonhard Stark,
  • Anja Pickhard,
  • Barbara Wollenberg and
  • Markus Wirth

21 February 2022

(1) Background: NOTCH1 is the second most common mutated gene in whole-exome sequencing of HNSCC. The aim of this project was to gain further insight into the relevance of NOTCH1 in HNSCC, potentially establishing NOTCH1 as a prognostic marker or the...

  • Review
  • Open Access
45 Citations
8,546 Views
24 Pages

Knowns and Unknowns about CAR-T Cell Dysfunction

  • Aleksei Titov,
  • Yaroslav Kaminskiy,
  • Irina Ganeeva,
  • Ekaterina Zmievskaya,
  • Aygul Valiullina,
  • Aygul Rakhmatullina,
  • Alexey Petukhov,
  • Regina Miftakhova,
  • Albert Rizvanov and
  • Emil Bulatov

21 February 2022

Immunotherapy using chimeric antigen receptor (CAR) T cells is a promising option for cancer treatment. However, T cells and CAR-T cells frequently become dysfunctional in cancer, where numerous evasion mechanisms impair antitumor immunity. Cancer fr...

of 25

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694